ANIK logo

ANIKAnika Therapeutics Inc.

$14.16
$0.25
(1.74%)
Pre-Market
Updated: 07:29 AM EDT·Prev Close $14.41
EarningsJul 29
Mkt Cap$191.73M
Vol413.00

About

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
235

Frequently Asked Questions

What is Market Cap of Anika Therapeutics Inc.?
What is the 52-week high for Anika Therapeutics Inc.?
What is the 52-week low for Anika Therapeutics Inc.?
What is Anika Therapeutics Inc. stock price today?
What was Anika Therapeutics Inc. stock price yesterday?
What is the PE ratio of Anika Therapeutics Inc.?
What is the Price-to-Book ratio of Anika Therapeutics Inc.?
What is the 50-day moving average of Anika Therapeutics Inc.?
How many employees does Anika Therapeutics Inc. have?